Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy, Safety, Reactogenicity and Immunogenicity Study of the Lyophilised Formulation of Rotarix Vaccine in Healthy Japanese Infants

NCT00480324 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT00480324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00480324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy, Safety, Reactogenicity and Immunogenicity Study of the Lyophilised Formulation of Rotarix Vaccine in Healthy Japanese Infants
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
June 19, 2007
Completion date
November 21, 2009
Enrollment
765 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

infections, rotavirus, rotavirus vaccines